About Jeffrey Whitmore
Form D filings for Impact Proteomics in 2024 list Jeffrey Whitmore as CEO and director.
Jeffrey Whitmore first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Whitmore in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Whitmore works with at each company, as listed on that company's latest Form D.
Impact Proteomics, LLC · Form D, Aug 14, 2024
JM
Jonathan Minden
Executive officer, director and promoter